Effect of labor on postpartum clearance of cell-free fetal DNA from the maternal circulation

2008 ◽  
Vol 28 (4) ◽  
pp. 304-308 ◽  
Author(s):  
L. Hui ◽  
J. I. Vaughan ◽  
M. Nelson
2015 ◽  
Vol 212 (1) ◽  
pp. S65-S66
Author(s):  
Edward Wolf ◽  
Victoria DeSantos ◽  
Christopher McNamara ◽  
Natalie Porat ◽  
Richard Miller ◽  
...  

2015 ◽  
Vol 3 (6) ◽  
pp. 489-491 ◽  
Author(s):  
Ron Hochstenbach ◽  
Peter G. J. Nikkels ◽  
Martin G. Elferink ◽  
Martijn A. Oudijk ◽  
Carla Oppen ◽  
...  

2019 ◽  
Vol 23 (3) ◽  
pp. 156-167
Author(s):  
sara mahmoud ◽  
hasnaa aboalwafa ◽  
Eman Ali ◽  
Nesma Ahmed ◽  
mohamed mahmoud ◽  
...  

2014 ◽  
Vol 428 ◽  
pp. 44-50 ◽  
Author(s):  
Gary J.W. Liao ◽  
Ann M. Gronowski ◽  
Zhen Zhao

2015 ◽  
Vol 6 (1) ◽  
pp. 5-9 ◽  
Author(s):  
B. Konečná ◽  
V. Borbélyová ◽  
P. Celec ◽  
B. Vlková

Cell-free fetal DNA in maternal circulation is higher during preeclampsia. It is unclear whether it is the cause or the consequence of the disease. The aim of this study was to prove whether injected rat fetal DNA induces preeclampsia-like symptoms in pregnant Wistar rats. They received daily i.p. injections of water or rat fetal DNA (400 μg) from gestation day 14 to 18. Blood pressure, proteinuria, placental and fetal weight were measured at gestation day 19. Plasma DNase activity, proteinuria and creatinine clearance were assessed. There was no significant difference in any of the measured parameters. The results of this study do not confirm the hypothesis that fetal DNA might induce preeclampsia. This is in contrast to others using human fetal DNA in mice. Further studies should be focused on the effects of fetal DNA from the same species protected from DNase activity.


2018 ◽  
Author(s):  
Meriem R. Durgud ◽  
Vili K. Stoyanova ◽  
Nikolay T. Popov ◽  
Danail S. Minchev ◽  
Hristo Y. Ivanov ◽  
...  

Reproduction ◽  
2018 ◽  
Vol 155 (3) ◽  
pp. R137-R145 ◽  
Author(s):  
Sara R van Boeckel ◽  
Donald J Davidson ◽  
Jane E Norman ◽  
Sarah J Stock

Inflammation is known to play a key role in preterm and term parturition. Cell-free fetal DNA (cff-DNA) is present in the maternal circulation and increases with gestational age and some pregnancy complications (e.g. preterm birth, preeclampsia). Microbial DNA and adult cell-free DNA can be pro-inflammatory through DNA-sensing mechanisms such as Toll-like receptor 9 and the Stimulator of Interferon Genes (STING) pathway. However, the pro-inflammatory properties of cff-DNA, and the possible effects of this on pregnancy and parturition are unknown. Clinical studies have quantified cff-DNA levels in the maternal circulation in women who deliver preterm and women who deliver at term and show an association between preterm labor and higher cff-DNA levels in the 2nd, 3rd trimester and at onset of preterm birth symptoms. Together with potential pro-inflammatory properties of cff-DNA, this rise suggests a potential mechanistic role in the pathogenesis of spontaneous preterm birth. In this review, we discuss the evidence linking cff-DNA to adverse pregnancy outcomes, including preterm birth, obtained from preclinical and clinical studies.


2011 ◽  
Vol 17 (7) ◽  
pp. 434-438 ◽  
Author(s):  
N. R. Treff ◽  
X. Tao ◽  
J. Su ◽  
A. Lonczak ◽  
L. E. Northrop ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document